Diabetes is a multi-factorial disorder that should be treated with multi-effective compounds. Here we describe the access to polyhydroxylated pyrrolidines, belonging to the d-gluco and d-galacto series, through aminocyclization reactions of two differentially protected d-xylo-hexos-4-ulose derivatives. The prepared compounds proved to inhibit both alpha-glucosidase, responsible for the emergence of
糖尿病是一种多因素疾病,应使用多种有效化合物治疗。在这里,我们描述了获得多羟基
吡咯烷,属于d -
葡萄糖和d -半
乳糖系列,通过两个差异保护的aminocyclization反应d -
低聚木糖-hexos-4酮糖的衍
生物。所制备的化合物被证实既抑制了导致高血糖尖峰出现的α-
葡萄糖苷酶,又抑制了糖尿病组织异常发展的醛糖还原酶。因此,它们显示出双重抑制谱,被认为是糖尿病治疗的理想选择。明显地,化合物17b 当在类似感光体的661w
细胞系中进行测试时,可减少
细胞死亡的过程并恢复氧化应激的生理
水平,从而证明在糖尿病性视网膜病变的体外模型中有效。